CHARACTERIZATION OF CD38 EXPRESSION IN T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL) PATIENTS

被引：0
作者：
Buson, E. [1 ,2 ]
Calabretto, G. [1 ,2 ]
Burattin, A. [4 ]
Gasparini, V. R. [1 ,2 ]
Orsi, S. [4 ]
Rampazzo, E. [1 ,2 ]
Teramo, A. [1 ,2 ]
Trimarco, V. [1 ]
Manni, S. [1 ,2 ]
Barila, G. [1 ,3 ]
Facco, M. [1 ,2 ]
Bortoluzzi, S. [4 ]
Trentin, L. [1 ]
Semenzato, G. [1 ,2 ]
Zambello, R. [1 ,2 ]
机构：
[1] Padova Univ, Sch Med, Dept Med, Hematol Div, Padua, Italy
[2] Veneto Inst Mol Med VIMM, Padua, Italy
[3] Vicenza Hosp, Hematol Div, Vicenza, Italy
[4] Univ Padua, Dept Mol Med, Padua, Italy
来源：
HAEMATOLOGICA | 2024年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P068
引用
收藏
页码：91 / 91
页数：1
相关论文
共 50 条
  • [31] First report of clinical response to venetoclax combination with pentostatin in T-cell-prolymphocytic leukemia (T-PLL)
    Alfayez, Mansour
    Thakral, Beenu
    Jain, Preetesh
    Ravandi, Farhad
    Ferrajoli, Alessandra
    Jain, Nitin
    Pemmaraju, Naveen
    Wierda, William
    Kadia, Tapan
    LEUKEMIA & LYMPHOMA, 2020, 61 (02) : 445 - 449
  • [32] Evaluation of CD38 Expression in T-cell Lymphoproliferative Disorders
    Grant, Michelle L.
    Lunde, John H.
    Devitt, Katherine A.
    Gardner, Juli-Anne
    MODERN PATHOLOGY, 2017, 30 : 352A - 352A
  • [33] Subgroups of T-Cell Prolymphocytic Leukemia (T-PLL) Discovered By High-Throughput Ex Vivo Drug Testing and Genetic Profiling
    Andersson, Emma I.
    Adnan, Shady
    Sellner, Leopold
    Bellanger, Dorine
    Schrader, Alexandra
    Crispatzu, Giuliano
    Zhang, Henan
    Mateos, Carlos C.
    Faber, Edgar
    Koschmieder, Steffen
    Brummendorf, Tim H.
    Wennerberg, Krister
    Ding, Wei
    Stern, Marc-Henri
    Herling, Marco
    Anders, Simon
    Huber, Wolfgang
    Zenz, Thorsten
    Mustjoki, Satu
    BLOOD, 2015, 126 (23)
  • [34] Interleukin-2-inducible T-cell Kinase (ITK) Targeting by BMS-509744 Does Not Affect Cell Viability in T-cell Prolymphocytic Leukemia (T-PLL)
    Dondorf, Sabine
    Schrader, Alexandra
    Herling, Marco
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (16) : 10568 - 10569
  • [35] Immunophenotypic Characterization of T-Cell Prolymphocytic Leukemia
    Chen, Xueyan
    Cherian, Sindhu
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 140 (05) : 727 - 735
  • [36] In vitro and in vivo effectiveness of arsenic trioxyde in a murine form of T prolymphocytic leukemia (T-PLL).
    Recher, C
    Chopin, M
    Dombret, H
    Sigaux, F
    Stern, MH
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [37] Campath 1H in 5 T4-prolymphocytic leukemia (T-PLL).
    Cazin, B
    Wetterwald, M
    Bonnevie, F
    Cambier, N
    Taillefer, MF
    Jouet, JP
    Bauters, F
    BLOOD, 1998, 92 (10) : 275B - 275B
  • [38] CD8+ T-cell prolymphocytic leukemia
    Nakajima, H
    Oki, M
    Ando, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) : 560 - 562
  • [39] High CD38 expression in childhood T-cell acute lymphoblastic leukemia is not associated with prognosis
    Liao, Chan
    Shen, Di-Ying
    Xu, Xiao-Jun
    Song, Hua
    Xu, Wei-Qun
    Zhao, Fen-Ying
    Yang, Shi-Long
    Tang, Yong-Min
    CANCER BIOMARKERS, 2020, 27 (02) : 277 - 284
  • [40] PROGNOSTIC VALUE OF T-CELL CD38 EXPRESSION IN B-CHRONIC LYMPHOCYTIC LEUKEMIA
    Abousamra, N. K.
    El-Din, M. S.
    Azmy, E. A.
    ANNALS OF ONCOLOGY, 2012, 23 : 22 - 22
12345